CHLAMYDIA - ANVISA Registration 10259610211

Access comprehensive regulatory information for CHLAMYDIA in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10259610211 and manufactured by VIRCELL S.L.. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Sep 19, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG, VIRCELL S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10259610211
2 Related Devices
Registration Details
ANVISA Registration Number: 10259610211
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CHLAMYDIA TRACHOMATIS VIRCLIA IgA MONOTEST
Risk Class IV

Registration Details

10259610211

25351142335202340

68814961000173

Company Information

VIRCELL S.L.
Spain
PT: ESPANHA

Dates and Status

Mar 27, 2023

19/09/2026

09/18/2025 19:00:01

CHLAMYDIA TRACHOMATIS VIRCLIA IgA MONOTEST
Risk Class IV

Registration Details

10259610211

25351142335202340

68814961000173

Company Information

Dates and Status

Mar 27, 2023

19/09/2026

09/18/2025 19:00:01